TopGum Industries
TopGum Industries is an Israeli B2B CDMO (contract development and manufacturing organization) producing functional gummy supplements — including women's health, beauty, gut health, and sports nutrition — for nutraceutical brands, pharmaceutical companies, and major retailers, using proprietary sugar-free matrix and microencapsulation technologies across manufacturing facilities in Israel, Canada, and the United States.
- Company typePublic
- Founded2005
- HeadquartersSderot, Israel
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What TopGum Industries does
TopGum Industries Ltd. is an Israeli B2B contract development and manufacturing organization (CDMO) specializing in functional gummy supplements for nutraceutical brands, pharmaceutical companies, and major retailers. Founded in 2004/2005 and listed on the Tel Aviv Stock Exchange (TASE:1943 / TLV:TPGM), the company operates from Sderot, Israel with manufacturing facilities across two continents — a new Sderot facility launched in 2025, a 65,000 sq ft facility on Prince Edward Island, Canada acquired through Island Abbey Nutritionals (March 2025), and the first U.S.-based FDA-compliant manufacturing platform acquired from P&L Developments (May 2026, up to $35M consideration).
The company's core technology is a proprietary gummy formulation and manufacturing platform built on three pillars: the Gummiceuticals Sugar-Free Matrix (a patented prebiotic fiber-based delivery system using fructooligosaccharide/FOS), TopCaps MicroEncapsulation (preserves ingredient integrity and masks challenging flavors), and a High Dose Platform enabling high active-ingredient loading without compromising taste or texture. These underpin five product categories — Women's Health, Beauty From Within (nutricosmetics), Gut Health (pre/pro/postbiotics), Immune Shield, and Active Lifestyle (electrolyte, creatine, hydration, magnesium, recovery gummies) — offered through custom, white-label, and private-label manufacturing.
TopGum generates revenue through manufacturing fees under multi-year B2B contracts with quote-based pricing. FY2025 revenue mix was 77% nutrition supplements ($78.1M, ~109% YoY growth). A strategic supply agreement with a major unnamed U.S. brand exceeded $25M through 2026. Pharmaceutical-grade gummies from the FDA-compliant U.S. platform are targeted for commercial launch in 2027-2028. FY2025 revenue was $100.95M (~70% YoY growth) with $15.7M Adjusted EBITDA; Q1 2026 revenue reached $31.9M (+85% YoY) with a record $52M order backlog, signaling continued strong momentum.
TopGum Industries firmographics
Firmographics- Name
- TopGum Industries
- Legal name
- TopGum Industries Ltd.
- Website
- https://topgummiceuticals.com
- Company type
- Public
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- TopGum Industries is an Israeli B2B CDMO (contract development and manufacturing organization) producing functional gummy supplements — including women's health, beauty, gut health, and sports nutrition — for nutraceutical brands, pharmaceutical companies, and major retailers, using proprietary sugar-free matrix and microencapsulation technologies across manufacturing facilities in Israel, Canada, and the United States.
- Ownership category
- akta.pro rank
TopGum Industries industry classification
Industry- Product category
- Nutraceutical Contract Manufacturing
- NAICS
- Nonchocolate Confectionery Manufacturing (311340)
- SIC
- Sugar & Confectionery Products (2060)
- akta.pro primary industry
- Confectionery Manufacturing (Chocolate, Candy, Gum) (AFAKAAAD)
Keywords
Where TopGum Industries is headquartered
LocationHeadquarters
- HQ city
- Sderot
- HQ country
- Israel
- HQ region
- Middle East
Offices4 records
Markets served
TopGum Industries business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Contract Manufacturing (B2B/CDMO): Contract development and manufacturing services for dietary supplement brands, pharmaceutical companies, and retailers. Generates revenue through manufacturing fees for white-label and private-label gummy supplement production. Revenue mix includes nutrition supplements (77% of 2025 revenue), with pharmaceutical gummy products targeted for commercial launch in 2027-2028.
- Supply Agreements: Strategic supply agreements with major U.S. brands for supplement manufacturing. Example: $25 million+ supply agreement through 2026 with major U.S. brand. Revenue recognized from product shipments under multi-year contracts.
- Pharmaceutical Gummy Manufacturing: Pharmaceutical gummy manufacturing revenue from U.S. FDA-compliant operations. Expected to generate revenue starting 2026-2027 under major unnamed pharmaceutical partner's brands. Revenue model based on manufacturing fees for pharmaceutical-grade products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B contract manufacturing pricing |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
TopGum Industries product offering
Product offeringCore offering
TopGum Industries is a contract development and manufacturing organization (CDMO) that produces custom, white-label, and private-label functional gummy supplements for nutraceutical brands, pharmaceutical companies, and retailers. The company manufactures gummy products across five categories (Women's Health, Beauty From Within, Gut Health, Immune Shield, Active Lifestyle) using proprietary technologies including a patented sugar-free prebiotic fiber matrix, microencapsulation, and high-dose active ingredient delivery platforms. Manufacturing operations span facilities in Israel, Canada, and the United States.
Product overview
TopGum Industries is a gummy supplement contract manufacturer and technology provider offering a portfolio of proprietary technology platforms (Gummiceuticals Sugar-Free Matrix, TopCaps MicroEncapsulation, High Dose Platform) and five product categories: Women's Health, Beauty From Within, Gut Health, Immune Shield, and Active Lifestyle. The company provides custom, white-label, and private-label gummy supplements through its manufacturing facilities across two continents, leveraging specialized technologies for sugar-free formulations, microencapsulation, and high-dose active delivery. Product offerings span botanical women's wellness gummies (Shatavari), beauty-from-within nutricosmetic formulations (HSN+, hyaluronic acid, collagen), hydration gummies (electrolyte), sports nutrition products (creatine, magnesium, recovery), and pre-/pro-/postbiotic digestive health formulas.
Differentiator
Problem solved
Functional benefit
Products and services
- Women's Health Gummies Tailor-made women's health gummy supplements supporting women through every life stage, from fertility and pregnancy to postpartum recovery and menopause, delivered via proprietary Gummiceuticals Sugar-Free Matrix technology.
- Beauty From Within Gummies Beauty-from-within nutricosmetic gummies featuring HSN+ (hair, skin, nails), hyaluronic acid, and collagen formulations designed to enhance inner radiance with proprietary Gummiceuticals technology.
- Gut Health Gummies Digestive health gummies addressing the rising demand for digestive health with innovative, easy-to-take supplement formats supporting nutrient absorption, immune function, mood, and energy levels. Includes pre-, pro-, and postbiotic formulas.
- Immune Shield Gummies Immune support gummies formulated to fortify the body's natural defenses with essential nutrients against daily health challenges.
- Active Lifestyle Gummies Expertly crafted active lifestyle formulations enhancing energy, endurance, strength, and recovery, including electrolyte, creatine, energy, magnesium, and recovery gummies — providing convenient alternatives to traditional shakes, gels, and powders.
- High-Dose Electrolyte / Hydration Gummies High-dose electrolyte / hydration gummies formulated with proprietary fiber matrix technology incorporating fructooligosaccharide (FOS) and encapsulation techniques for bioactives, addressing high sugar content and low active ingredient payload challenges in hydration and electrolyte gummies.
- Contract Manufacturing & White-Label CDMO Services Custom, white-label, and private-label gummy supplement contract development and manufacturing services for dietary supplement brands, pharmaceutical companies, and retailers. Includes formulation R&D, manufacturing, and packaging solutions (bottles, sachets, pouches, on-the-go formats).
- FDA Pharmaceutical-Compliant Gummy Manufacturing FDA pharmaceutical-compliant manufacturing for pharmaceutical partners producing gummy-formulated medications and supplements under major pharmaceutical partner brands. Provides FDA 21 CFR Part 11 compliant manufacturing capabilities with integration expected through 2026.
Quantifiable outcome
- 162% surge in dietary supplements segment revenue in Q1 2026 year-over-year
- +4 more outcomes
Companies that use TopGum Industries
Customer profileNamed customers2 records
Segments6 records
Ideal customer profiles3 records
TopGum Industries technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
TopGum Industries partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- P&L Developments LLCcoreTopGum completed acquisition of P&L Developments' U.S. gummy manufacturing operations for up to $35 million ($10M cash, ~$8M shares, up to $17M contingent consideration). The transaction gives TopGum its first U.S.-based FDA pharmaceutical-compliant manufacturing platform. In return, PLD gains privileged access to distribute TopGum products to major U.S. retailers under store-brand labels.
- Major U.S. RetailerscoreStrategic commercial partnership through which PLD distributes TopGum products to major U.S. retailers under store-brand labels, expanding TopGum's presence in primary target market.
- Unnamed Major Pharmaceutical PartnercoreStrategic partnership for pharmaceutical gummy products expected to begin commercial launch in 2027-2028 under major unnamed pharmaceutical partner's brands. Represents TopGum's entry into pharmaceutical gummy sector.
- Island Abbey NutritionalscoreTopGum acquired Island Abbey Nutritionals, a contract development and manufacturing organization (CDMO) specializing in gummy and lozenge supplements located on Prince Edward Island, Canada. The acquisition expanded TopGum's manufacturing capabilities in North America with a 65,000 sq ft facility featuring starchless depositing, center-fill capabilities, and automated bottling and packaging lines.
- GOOMminorGOOM, a vegan and sugar-free gummy supplement startup founded by Israeli paratroopers, partnered with TopGum to produce their supplements after being rejected by multiple Israeli factories. GOOM achieved 1,200% sales growth in early 2026 with tens of millions of shekels in revenue.
- PharmItBe, Ltd.coreTopGum acquired PharmItBe, an FDA-certified analytical laboratory, to enhance pharma-grade gummy development, improve supply chain efficiency, and expand analytical capabilities. The acquisition included appointment of Dr. Evgenia Lozinsky as Head of R&D. A new facility supported by $40 million investment was planned to open by year-end 2023.
Scale indicators12 records
Recent moves8 records
Expansion highlights7 records
TopGum Industries competitors and assessment
Company assessmentDirect peers
- Procaps Group: Colombian-headquartered, NYSE-listed CDMO with softgel and gummy supplement manufacturing serving global nutraceutical brands. Closest publicly traded peer to TopGum by business model (B2B contract manufacturing of gummy/softgel supplements), customer base (nutraceutical brands), and geographic model (manufacturing in lower-cost regions serving U.S./global demand).
- Gemini Pharmaceuticals: U.S.-based contract manufacturer of liquid, powder, tablet, and gummy dietary supplements serving nutraceutical brands. Comparable B2B CDMO model in adjacent product formats to TopGum.
- Captek Softgel International: U.S.-based contract manufacturer specializing in softgel and gummy supplement production for dietary supplement and OTC brands. Directly comparable CDMO model with gummy manufacturing as a core capability.
- Best Formulations: U.S.-based nutraceutical contract manufacturer offering gummy, softgel, tablet, and capsule capabilities for dietary supplement brands. Comparable CDMO model serving the same U.S. brand customers TopGum targets.
- Vitakem: U.S.-headquartered contract manufacturer specializing in gummy dietary supplements for nutraceutical brands. Direct peer in gummy CDMO space with similar customer profile and product format focus.
- Sirio Pharma: China-based global nutraceutical CDMO with explicit gummy supplement manufacturing capabilities serving brand customers across North America, Europe, and Asia. Highly comparable B2B contract manufacturing model targeting the same dietary supplement end-market as TopGum.
- Contract Pharmacal Corp: U.S.-based nutraceutical and OTC pharmaceutical CDMO with capabilities in gummy, softgel, tablet, and capsule manufacturing. Comparable CDMO model targeting similar dietary supplement and pharmaceutical customer segments.
Broad incumbents
- Catalent: Major global CDMO (now owned by Novo Holdings) offering softgel, gummy, and oral dose manufacturing for pharmaceutical and consumer health customers. A much larger incumbent with broader capabilities, but operates in the same contract manufacturing space TopGum is moving into for pharmaceutical gummies.
- Lonza Consumer Health & Nutrition: Swiss-listed global CDMO with consumer health and nutrition capabilities including gummy formats. Operates in the same end-markets as TopGum but at much larger scale and across a far broader portfolio of dosage forms.
- Aenova Group: European-headquartered CDMO serving pharmaceutical and nutraceutical customers with solid, semi-solid, and oral dose forms including gummies. Larger incumbent with overlapping capabilities to TopGum, particularly relevant for European customer acquisition.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
TopGum Industries social profiles
Digital presenceTopGum Industries compliance and trust
Trust signalCompliance2 records
TopGum Industries financial estimates
Financial estimateRevenue estimate
Valuation estimate
TopGum Industries leadership team
Management profileNumber of profiles
Profiles5 records
TopGum Industries subsidiaries and ownership
Company hierarchySubsidiaries3 records
TopGum Industries funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TopGum Industries M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TopGum Industries
What does TopGum Industries do?
TopGum Industries is a contract development and manufacturing organization (CDMO) that produces custom, white-label, and private-label functional gummy supplements for nutraceutical brands, pharmaceutical companies, and retailers. The company manufactures gummy products across five categories (Women's Health, Beauty From Within, Gut Health, Immune Shield, Active Lifestyle) using proprietary technologies including a patented sugar-free prebiotic fiber matrix, microencapsulation, and high-dose active ingredient delivery platforms. Manufacturing operations span facilities in Israel, Canada, and the United States.
Is TopGum Industries a public or private company?
TopGum Industries is a public company. It is classified as public and is currently operating.
When was TopGum Industries founded?
TopGum Industries was founded in 2005. It employs 251 to 500 people.
Where is TopGum Industries based?
TopGum Industries is headquartered in Sderot, Israel, in the Middle East region.
How does TopGum Industries make money?
Three revenue lines are on record. Contract Manufacturing (B2B/CDMO) is the primary driver. The others are supply Agreements and pharmaceutical Gummy Manufacturing.
Who are TopGum Industries's main competitors?
Direct peers on record are Procaps Group, Gemini Pharmaceuticals, Captek Softgel International, Best Formulations, Vitakem, Sirio Pharma and Contract Pharmacal Corp. Broad incumbents are Catalent, Lonza Consumer Health & Nutrition and Aenova Group.
Does TopGum Industries have an API?
No public API is recorded for TopGum Industries.
What industry is TopGum Industries in?
TopGum Industries's product category is Nutraceutical Contract Manufacturing. Its primary akta.pro industry code is AFAKAAAD, Confectionery Manufacturing (Chocolate, Candy, Gum). Its NAICS code is 311340 and its SIC code is 2060.